Funding for this research was provided by:
Cancerfonden (CAN 2017/600, 20 1308 PjF)
Stiftelsen Assar Gabrielssons Fond (FB 17-83, FB20-112)
Grants from the Swedish state under the agreement between the Swedish government and the country councils, the ALF-agreement
Sahlgrenska Universitetssjukhuset (C4A-2019, C4A-2020)
University of Gothenburg
Received: 4 October 2021
Accepted: 30 January 2022
First Online: 14 February 2022
: The study has been approved by the Regional Ethical Review Board in Gothenburg (Dnr: 938–16) and the Swedish Ethical Review Authority (Dnr: 2019–01556).
: Written informed consent was obtained from all patients.
: The authors declare that they have no competing interests.